Michelle Avery
Contacto de Relaciones con Inversores en PANDION THERAPEUTICS, INC. .
Cargos activos de Michelle Avery
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PANDION THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/09/2020 | - |
Historial de carrera de Michelle Avery
Antiguos cargos conocidos de Michelle Avery.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Contacto de Relaciones con Inversores | - | - |
| Public Communications Contact | - | - |
Estadísticas
Internacional
| Reino Unido | 2 |
| Estados Unidos | 2 |
Operativa
| Investor Relations Contact | 2 |
| Public Communications Contact | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Michelle Avery
- Experiencia
